Cargando…
Active Compounds Derived from Fuzheng Huayu Formula Protect Hepatic Parenchymal Cells from Apoptosis Based on Network Pharmacology and Transcriptomic Analysis
Fuzheng huayu formula (FZHY), an antifibrotic traditional Chinese medicine, is frequently used for the treatment of liver fibrosis. In this study, network analysis, transcriptomic analysis, assays of cell apoptosis, viability and protein expression were used for investigating the effects and mechani...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6358846/ https://www.ncbi.nlm.nih.gov/pubmed/30669350 http://dx.doi.org/10.3390/molecules24020338 |
_version_ | 1783392083133857792 |
---|---|
author | Wu, Rong Dong, Shu Cai, Fei-Fei Chen, Xiao-Le Yang, Meng-Die Liu, Ping Su, Shi-Bing |
author_facet | Wu, Rong Dong, Shu Cai, Fei-Fei Chen, Xiao-Le Yang, Meng-Die Liu, Ping Su, Shi-Bing |
author_sort | Wu, Rong |
collection | PubMed |
description | Fuzheng huayu formula (FZHY), an antifibrotic traditional Chinese medicine, is frequently used for the treatment of liver fibrosis. In this study, network analysis, transcriptomic analysis, assays of cell apoptosis, viability and protein expression were used for investigating the effects and mechanisms of compounds derived from FZHY on hepatic parenchymal cell (HPC) protection and hepatic stellate cell activation. Network pharmacology analysis found that 6 major compounds and 39 potential targets were important network nodes. Our analysis predicted that the active compounds of FZHY, including hederagenin, luteolin and tanshinone IIA inhibited cell apoptosis (p < 0.05), increased PI3K expression and reduced cleaved caspase 3 expression and the Bax/Bcl-w ratio (p < 0.05) in L02 cells that had apoptosis induced by TNF-α. Few significant changes caused by FZHY, hederagenin, luteolin and tanshinone IIA were observed in hepatic stellate Lx2 cells upon TGF-β1 induction. These data suggest that FZHY is active against liver fibrosis, protects hepatic parenchymal cells from apoptosis, and recovers liver function, possibly through the effects of its active compounds hederagenin, luteolin and tanshinone IIA and is involved in the inhibition of apoptosis in HPCs, possibly through regulating the PI3K, ERK, cleaved caspase 3 and Bax/Bcl-w levels. |
format | Online Article Text |
id | pubmed-6358846 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-63588462019-02-06 Active Compounds Derived from Fuzheng Huayu Formula Protect Hepatic Parenchymal Cells from Apoptosis Based on Network Pharmacology and Transcriptomic Analysis Wu, Rong Dong, Shu Cai, Fei-Fei Chen, Xiao-Le Yang, Meng-Die Liu, Ping Su, Shi-Bing Molecules Article Fuzheng huayu formula (FZHY), an antifibrotic traditional Chinese medicine, is frequently used for the treatment of liver fibrosis. In this study, network analysis, transcriptomic analysis, assays of cell apoptosis, viability and protein expression were used for investigating the effects and mechanisms of compounds derived from FZHY on hepatic parenchymal cell (HPC) protection and hepatic stellate cell activation. Network pharmacology analysis found that 6 major compounds and 39 potential targets were important network nodes. Our analysis predicted that the active compounds of FZHY, including hederagenin, luteolin and tanshinone IIA inhibited cell apoptosis (p < 0.05), increased PI3K expression and reduced cleaved caspase 3 expression and the Bax/Bcl-w ratio (p < 0.05) in L02 cells that had apoptosis induced by TNF-α. Few significant changes caused by FZHY, hederagenin, luteolin and tanshinone IIA were observed in hepatic stellate Lx2 cells upon TGF-β1 induction. These data suggest that FZHY is active against liver fibrosis, protects hepatic parenchymal cells from apoptosis, and recovers liver function, possibly through the effects of its active compounds hederagenin, luteolin and tanshinone IIA and is involved in the inhibition of apoptosis in HPCs, possibly through regulating the PI3K, ERK, cleaved caspase 3 and Bax/Bcl-w levels. MDPI 2019-01-18 /pmc/articles/PMC6358846/ /pubmed/30669350 http://dx.doi.org/10.3390/molecules24020338 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Wu, Rong Dong, Shu Cai, Fei-Fei Chen, Xiao-Le Yang, Meng-Die Liu, Ping Su, Shi-Bing Active Compounds Derived from Fuzheng Huayu Formula Protect Hepatic Parenchymal Cells from Apoptosis Based on Network Pharmacology and Transcriptomic Analysis |
title | Active Compounds Derived from Fuzheng Huayu Formula Protect Hepatic Parenchymal Cells from Apoptosis Based on Network Pharmacology and Transcriptomic Analysis |
title_full | Active Compounds Derived from Fuzheng Huayu Formula Protect Hepatic Parenchymal Cells from Apoptosis Based on Network Pharmacology and Transcriptomic Analysis |
title_fullStr | Active Compounds Derived from Fuzheng Huayu Formula Protect Hepatic Parenchymal Cells from Apoptosis Based on Network Pharmacology and Transcriptomic Analysis |
title_full_unstemmed | Active Compounds Derived from Fuzheng Huayu Formula Protect Hepatic Parenchymal Cells from Apoptosis Based on Network Pharmacology and Transcriptomic Analysis |
title_short | Active Compounds Derived from Fuzheng Huayu Formula Protect Hepatic Parenchymal Cells from Apoptosis Based on Network Pharmacology and Transcriptomic Analysis |
title_sort | active compounds derived from fuzheng huayu formula protect hepatic parenchymal cells from apoptosis based on network pharmacology and transcriptomic analysis |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6358846/ https://www.ncbi.nlm.nih.gov/pubmed/30669350 http://dx.doi.org/10.3390/molecules24020338 |
work_keys_str_mv | AT wurong activecompoundsderivedfromfuzhenghuayuformulaprotecthepaticparenchymalcellsfromapoptosisbasedonnetworkpharmacologyandtranscriptomicanalysis AT dongshu activecompoundsderivedfromfuzhenghuayuformulaprotecthepaticparenchymalcellsfromapoptosisbasedonnetworkpharmacologyandtranscriptomicanalysis AT caifeifei activecompoundsderivedfromfuzhenghuayuformulaprotecthepaticparenchymalcellsfromapoptosisbasedonnetworkpharmacologyandtranscriptomicanalysis AT chenxiaole activecompoundsderivedfromfuzhenghuayuformulaprotecthepaticparenchymalcellsfromapoptosisbasedonnetworkpharmacologyandtranscriptomicanalysis AT yangmengdie activecompoundsderivedfromfuzhenghuayuformulaprotecthepaticparenchymalcellsfromapoptosisbasedonnetworkpharmacologyandtranscriptomicanalysis AT liuping activecompoundsderivedfromfuzhenghuayuformulaprotecthepaticparenchymalcellsfromapoptosisbasedonnetworkpharmacologyandtranscriptomicanalysis AT sushibing activecompoundsderivedfromfuzhenghuayuformulaprotecthepaticparenchymalcellsfromapoptosisbasedonnetworkpharmacologyandtranscriptomicanalysis |